CLO20-060: Factors Associated with the Uptake of Adjuvant Pertuzumab in Patients with Stage I-III HER2-positive Breast Cancer: The University of Colorado Cancer Center Experience

Authors: Ericson Stoen, Jodi Kagihara, Peter Kabos, Christine Fisher, Jennifer R. Diamond

Published: 2020-03-20

DOI: 10.6004/jnccn.2019.7489

Source: Full article

---

Abstract

No abstract found.